Azenta, Inc. (NASDAQ:AZTA) Stock Position Lifted by Comerica Bank

Comerica Bank grew its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 153,430 shares of the company's stock after acquiring an additional 25,080 shares during the period. Comerica Bank owned about 0.34% of Azenta worth $7,672,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Ballentine Partners LLC raised its position in shares of Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares in the last quarter. Boothbay Fund Management LLC increased its stake in shares of Azenta by 8.4% in the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock worth $329,000 after buying an additional 509 shares during the last quarter. Picton Mahoney Asset Management raised its holdings in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after acquiring an additional 532 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Azenta by 14.9% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock valued at $225,000 after acquiring an additional 576 shares during the last quarter. Finally, KBC Group NV grew its holdings in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares in the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on AZTA. Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Needham & Company LLC increased their target price on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th.

Azenta Trading Down 3.0 %

NASDAQ AZTA traded down $0.78 during trading hours on Tuesday, reaching $25.42. The company's stock had a trading volume of 1,003,215 shares, compared to its average volume of 657,294. The stock has a market cap of $1.16 billion, a PE ratio of -8.53 and a beta of 1.64. The business has a 50-day simple moving average of $32.37 and a 200 day simple moving average of $42.37. Azenta, Inc. has a 52 week low of $24.06 and a 52 week high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.